Catalyst Wire Dossier Catalyst Wire Dossier

QRL-101

· QurAlis Corporation
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QRL-101, covering 2025-02-14 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants [Phase 1]

See pricing